SCHEMBL7367061

SCHEMBL7367061

CCN1CC(N2CCN(c3noc4cc(F)ccc34)CC2)N(CC)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.47
HTR2A P28223 11/20 0.47
HTR7 P34969 3/20 0.46
HTR1A P08908 3/20 0.45
KCNH2 Q12809 2/20 0.43
SLC6A4 P31645 1/20 0.39
HTR2C P28335 2/20 0.36
ACHE P22303 2/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
DRD1 P21728 1/20 0.36
DRD4 P21917 1/20 0.36
DRD5 P21918 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
DRD3 P35462 1/20 0.36
SCN5A Q14524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7365322 0.88 HTR2A (0.48) DRD2HTR2AHTR7HTR1AKCNH2
SCHEMBL8113107 0.77 HTR2A (0.60) DRD2HTR2AHTR7HTR1AKCNH2
SCHEMBL7368733 0.76 DRD2 (0.53) DRD2HTR2AHTR7HTR1AKCNH2
SCHEMBL13448255 0.76 HTR2A (0.60) DRD2HTR2AHTR7HTR1AKCNH2
SCHEMBL22302778 0.72 DRD2 (0.63) DRD2HTR2AHTR7HTR1AKCNH2
SCHEMBL7367433 0.72 DRD2 (0.55) DRD2HTR2AHTR7KCNH2SLC6A4
SCHEMBL7365706 0.72 DRD2 (0.55) DRD2HTR2AHTR7KCNH2SLC6A4
SCHEMBL7360772 0.70 DRD2 (0.53) DRD2HTR2AHTR1ASLC6A4HTR2C
SCHEMBL531012 0.69 ACHE (0.52) DRD2HTR2AHTR7HTR1AKCNH2
SCHEMBL7370354 0.69 DRD2 (0.52) DRD2HTR2AHTR7KCNH2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5780474-A ADMINISTERING IN THE TREATMENT OF PSYCHOTIC DISORDERS, ANXIO-DEPRESSIVE DISORDERS AND AGGRESSIVENESS ADIR ET COMPAGNIE (FR) 1998-07-14 US claimed
US-5780474-A ADMINISTERING IN THE TREATMENT OF PSYCHOTIC DISORDERS, ANXIO-DEPRESSIVE DISORDERS AND AGGRESSIVENESS ADIR ET COMPAGNIE (FR) 1998-07-14 US disclosed